From Target to Clinic: AI-Driven Antibody Discovery and Advanced Preclinical Models for Next-Gen Therapeutics
We are excited to invite you to Biocytogen Symposium Korea 2026, bringing together biopharmaceutical professionals, researchers, and industry experts to explore innovative approaches to next-generation therapeutic development. The event will also feature the grand opening ceremony of Biocytogen’s Korea subsidiary, marking an important milestone in our commitment to strengthening our presence in Korea and fostering local collaboration.
From AI-driven antibody discovery and next-generation ADCs to advanced humanized mouse models, this symposium will highlight cutting-edge technologies and preclinical strategies designed to accelerate drug discovery and development.
🔬 Scientific Highlights:
Session 1: RenSuper Biologics™: Empowering Antibody Plus Therapeutics with AI-Driven Precision and Scalability
Session 2: From Platform to Pipeline: Advancing Next-Generation ADCs with Biocytogen’s Integrated Platform
Session 3: Blood-Brain Barrier Penetration Strategies for CNS Therapeutics: Preclinical Validation and Functional Assessment Using Humanized Mouse Models
Session 4: Navigating Oncology Translation with Humanized Models and Comparative Oncology Insights
Session 5: Accelerating Autoimmune Drug Discovery: Humanized Mouse Models for Atopic Dermatitis and Asthma
📅 Date: November 12, 2026
🕐 Time: 13:00–17:30 (KST)
📍 Venue: Sofitel Ambassador Seoul Hotel & Serviced Residences, 4F, Grand Ballroom C, Seoul, Korea
🎁 Lucky Draw & Networking!
Connect with industry peers, exchange scientific insights, and enjoy our lucky draw featuring exciting prizes, including a tablet, coffee machines, and gift vouchers!
We look forward to welcoming you in Seoul for an afternoon of scientific exchange, innovation, and meaningful connections.
🔗 Register now: https://forms.gle/EMWGep3xzjx4Mrvc9
